| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/07/2002 | EP1007094B1 Pharmaceutical compositions comprising a nucleotide analogue suitable for freeze drying |
| 08/07/2002 | EP0835265B1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues |
| 08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
| 08/07/2002 | CN1362253A Medicine for increasing leucocyte and its preparation |
| 08/07/2002 | CN1362241A Nano gastrodia and sharpleaf gambirplant medicine and its preparation |
| 08/07/2002 | CN1362239A Nano Yixuesheng medicine for benefiting hemopoiesis and its preparation |
| 08/07/2002 | CN1362226A Nano medicine of ten medicinal plant ashes and its preparation |
| 08/07/2002 | CN1362222A Nanometer blood-nourishing and transquilizing medicine and its preparation |
| 08/07/2002 | CN1362211A Nano mixed zaofan medicine and its preparation |
| 08/07/2002 | CN1362208A Nano astragalus medicine and its preparation |
| 08/07/2002 | CN1362201A Nano Ankunzanyu medicine and its preparation |
| 08/07/2002 | CN1362198A Nano Chinese angelica medicine and its preparation |
| 08/07/2002 | CN1362195A Nano Jinkuishenqi medicine for invigorating kidney essence and its preparation |
| 08/07/2002 | CN1362193A Namo xinkeshu medicine and its preparation |
| 08/07/2002 | CN1362192A Nano xinnaoshutong medicine and its preparation |
| 08/07/2002 | CN1362191A Nano Folium Ginkgo medicine and its preparation |
| 08/07/2002 | CN1362171A Nano notoginseng medicine and its preparation |
| 08/07/2002 | CN1362166A Nano four-drug medicine and its preparation |
| 08/07/2002 | CN1362165A Nano spirulina medicine and its preparation |
| 08/07/2002 | CN1362117A Nano Qili medicine and its preparation |
| 08/07/2002 | CN1362103A Nano meridian passage dredging medicine and its preparation |
| 08/07/2002 | CN1362076A Nano thrombus dredging medicine and its preparation |
| 08/07/2002 | CN1362075A Nano blood stasis dispersing medicine and its preparation |
| 08/07/2002 | CN1088708C Amidine derivatives useful as anti-platelet aggreaction inhibitors and vasodilators and their use |
| 08/07/2002 | CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 08/06/2002 | US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 08/06/2002 | US6429223 Modified forms of pharmacologically active agents and uses therefor |
| 08/06/2002 | US6429222 Hypotensive agent, endothelial damage, arteriosclerosis, antidiabetic agents |
| 08/06/2002 | US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 08/06/2002 | US6429210 Orthorombic polymorph of clopidogrel hydrogen sulfate with improved stability and lower solubility; antithrombotic agent; specific crystal structure and thermodynamic properties |
| 08/06/2002 | US6429205 Anticoagulants |
| 08/06/2002 | US6429017 Thrombosis and hemostasis testing in vitro to determine the ability of blood to form clots and to break clots in vivo by measuring precipitates of blood products with anticoagulants or coagulants |
| 08/06/2002 | CA2208682C Fibrinogen receptor antagonists having substituted .beta.-amino acid residues and pharmaceutical compositions comprising the same |
| 08/01/2002 | WO2002059308A2 Method of diagnosing and treating cartilage disorders |
| 08/01/2002 | WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor |
| 08/01/2002 | WO2002059295A1 Novel serine protease mp493 |
| 08/01/2002 | WO2002059153A2 Anticoagulants and their uses |
| 08/01/2002 | WO2002059128A2 Process for preparing clopidogrel |
| 08/01/2002 | WO2002059100A1 Halogen compounds having thrombopoietin receptor agonism |
| 08/01/2002 | WO2002059099A1 Cyclic compounds having thrombopoietin receptor agonism |
| 08/01/2002 | WO2002059092A1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
| 08/01/2002 | WO2002059091A1 Process for preparation of cyanophenylbenzoic acid derivatives |
| 08/01/2002 | WO2002059087A1 Preparation of non-crystalline atorvastatin calcium |
| 08/01/2002 | WO2002059083A2 Novel compounds |
| 08/01/2002 | WO2002059065A2 Oligo or polyalkylene glycol-coupled thrombin inhibitors |
| 08/01/2002 | WO2002058750A2 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 08/01/2002 | WO2002058749A2 Carrier with solid fibrinogen and solid thrombin |
| 08/01/2002 | WO2002058731A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 08/01/2002 | WO2002058729A2 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
| 08/01/2002 | WO2002058716A2 Treatment of inflammatory bowel disease using growth factors |
| 08/01/2002 | WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | WO2002058676A1 Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles |
| 08/01/2002 | WO2002042278A3 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 08/01/2002 | WO2002040048A3 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis |
| 08/01/2002 | WO2002036761A9 Compositions and methods for the diagnosis of cancer |
| 08/01/2002 | WO2002022166A3 Tweak receptor agonists as anti-angiogenic agents |
| 08/01/2002 | WO2002016620A3 Modulation of stem cell differentiation |
| 08/01/2002 | WO2002008285A3 Il-17 molecules and uses thereof |
| 08/01/2002 | WO2002002505A3 Compounds to treat alzheimer's disease |
| 08/01/2002 | WO2001098352A3 Thrombomodulin analogs for pharmaceutical use |
| 08/01/2002 | WO2001096565A3 Binding agents: chimeric ligand/receptor proteins |
| 08/01/2002 | WO2001089538A3 Apoptotic entities for use in treatment of endothelium dysfunction disorders |
| 08/01/2002 | WO2001083554A3 Anti-inflammatory compounds and uses thereof |
| 08/01/2002 | WO2001082953A3 Methods for treatment of diseases associated with inflammation under non-ischemic conditions |
| 08/01/2002 | WO2001072836A3 G-protein coupled receptors |
| 08/01/2002 | WO2001070738A3 Tri-aryl-substituted-ethane pde4 inhibitors |
| 08/01/2002 | WO2001041754A9 Inhibitors of collagen-induced platelet aggregation |
| 08/01/2002 | US20020103379 Making 2,2-difluoro-2-(2-pyridyl)-ethan-1-ol, by coupling 2-bromopyridine with ethyl 2-bromo-2,2-difluoroacetate, using metallic copper and solvent; chemical intermediates |
| 08/01/2002 | US20020103334 Aprotinin variants having a net charge of +3 to -3 at pH 7 and with the amino acids Arg15 or Arg15-Ala17 in the binding region; serine protease inhibitor |
| 08/01/2002 | US20020103248 Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal |
| 08/01/2002 | US20020103242 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 08/01/2002 | US20020103227 Nitric oxide synthase inhibitors such as 6(4'-(4-phenethyl-piperazin-1-ylmethyl)-biphenyl-4-yl)-pyridin-2-ylamine for treatment and prevention of central nervous system disorders |
| 08/01/2002 | US20020103225 Comprises solid amorphous dispersion of compounds such as (2R,4S)4-((3,5-dichloro-benzyl)-methoxycarbonyl-amino)-6,7-dimethoxy-2 -methyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester for elevating plasma lipid levels |
| 08/01/2002 | US20020103221 Such as 2-amino-N-(2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo -(4,3-c)pyridin-5-yl)-1-(R)-benzyloxymethyl- 2-oxo-ethyl)-isobutyramide or prodrug thereof; for improving functional health of elderly/isolated |
| 08/01/2002 | US20020103202 Heteroaryl-phenyl substituted factor Xa inhibitors |
| 08/01/2002 | US20020103111 Comprising peptide sequences which mimic the conserved amino acid motif LDTSL of MAdCAM-1 and which have groups bonded to the N- and C- termini; treatment of inflammatory bowel disease |
| 08/01/2002 | US20020102730 Expression system for factor VIII |
| 08/01/2002 | US20020102710 Polypeptide for use in the treatment of cancer, autoimmune diseases and inflammation |
| 08/01/2002 | US20020102535 Nucleic acid molecules and polypeptides for immune modulation |
| 08/01/2002 | DE10102878A1 Oligo- oder Polyalkylengekoppelte Thrombininhibitoren Oligo- or Polyalkylengekoppelte thrombin inhibitors |
| 08/01/2002 | CA2436139A1 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
| 08/01/2002 | CA2435143A1 Halogen compounds having thrombopoietin receptor agonism |
| 08/01/2002 | CA2434436A1 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 08/01/2002 | CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | CA2428084A1 Treatment of inflammatory bowel disease using growth factors |
| 08/01/2002 | CA2426102A1 Method of diagnosing and treating cartilaginous disorders |
| 07/31/2002 | EP1227152A1 Bacterial strain and genome of bifidobacterium |
| 07/31/2002 | EP1227083A1 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN $g(a)v$g(b)3 ANTAGONISTS |
| 07/31/2002 | EP1226829A2 Stabilised liquid preparations of the protease or its proenzyme which activitate the blood coagulation factor VII |
| 07/31/2002 | EP1226827A1 An anti-oedema composition,in particular for pharmaceutical use. |
| 07/31/2002 | EP1226822A2 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same |
| 07/31/2002 | EP1226249A2 Follistatin-related protein zfsta4 |
| 07/31/2002 | EP1226246A1 Polypeptides with expanded primary signalling motifs |
| 07/31/2002 | EP1226245A2 Hybrid adaptor receptors |
| 07/31/2002 | EP1226244A2 Polypeptides with non-natural primary signalling motifs |
| 07/31/2002 | EP1226178A1 Recombinant fusion molecules |
| 07/31/2002 | EP1226165A2 Peptides and pharmaceutical compositions comprising same |
| 07/31/2002 | EP1226160A2 Novel antiarrhythmic peptides |